These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

323 related articles for article (PubMed ID: 36110206)

  • 1. Recent advances of the mammalian target of rapamycin signaling in mesenchymal stem cells.
    Cai H; Wang Z; Tang W; Ke X; Zhao E
    Front Genet; 2022; 13():970699. PubMed ID: 36110206
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mammalian target of rapamycin (mTOR) as a potential therapeutic target in various diseases.
    Kaur A; Sharma S
    Inflammopharmacology; 2017 Jun; 25(3):293-312. PubMed ID: 28417246
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mesenchymal stem cells-derived IL-6 activates AMPK/mTOR signaling to inhibit the proliferation of reactive astrocytes induced by hypoxic-ischemic brain damage.
    He M; Shi X; Yang M; Yang T; Li T; Chen J
    Exp Neurol; 2019 Jan; 311():15-32. PubMed ID: 30213506
    [TBL] [Abstract][Full Text] [Related]  

  • 4. mTOR signaling in stem and progenitor cells.
    Meng D; Frank AR; Jewell JL
    Development; 2018 Jan; 145(1):. PubMed ID: 29311260
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of autophagy and mTOR signaling in neural differentiation of bone marrow mesenchymal stem cells.
    Li Y; Wang C; Zhang G; Wang X; Duan R; Gao H; Peng T; Teng J; Jia Y
    Cell Biol Int; 2014 Nov; 38(11):1337-43. PubMed ID: 24890505
    [TBL] [Abstract][Full Text] [Related]  

  • 6. IFN-γ orchestrates mesenchymal stem cell plasticity through the signal transducer and activator of transcription 1 and 3 and mammalian target of rapamycin pathways.
    Vigo T; Procaccini C; Ferrara G; Baranzini S; Oksenberg JR; Matarese G; Diaspro A; Kerlero de Rosbo N; Uccelli A
    J Allergy Clin Immunol; 2017 May; 139(5):1667-1676. PubMed ID: 27670240
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Upstream of the mammalian target of rapamycin: do all roads pass through mTOR?
    Corradetti MN; Guan KL
    Oncogene; 2006 Oct; 25(48):6347-60. PubMed ID: 17041621
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Autophagy activation: a novel mechanism of atorvastatin to protect mesenchymal stem cells from hypoxia and serum deprivation via AMP-activated protein kinase/mammalian target of rapamycin pathway.
    Zhang Q; Yang YJ; Wang H; Dong QT; Wang TJ; Qian HY; Xu H
    Stem Cells Dev; 2012 May; 21(8):1321-32. PubMed ID: 22356678
    [TBL] [Abstract][Full Text] [Related]  

  • 9. mTOR inhibition improves the immunomodulatory properties of human bone marrow mesenchymal stem cells by inducing COX-2 and PGE
    Wang B; Lin Y; Hu Y; Shan W; Liu S; Xu Y; Zhang H; Cai S; Yu X; Cai Z; Huang H
    Stem Cell Res Ther; 2017 Dec; 8(1):292. PubMed ID: 29287601
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Coordinated time-dependent modulation of AMPK/Akt/mTOR signaling and autophagy controls osteogenic differentiation of human mesenchymal stem cells.
    Pantovic A; Krstic A; Janjetovic K; Kocic J; Harhaji-Trajkovic L; Bugarski D; Trajkovic V
    Bone; 2013 Jan; 52(1):524-31. PubMed ID: 23111315
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mammalian target of rapamycin and tuberous sclerosis complex.
    Wataya-Kaneda M
    J Dermatol Sci; 2015 Aug; 79(2):93-100. PubMed ID: 26051878
    [TBL] [Abstract][Full Text] [Related]  

  • 12. mTOR signaling as a molecular target for the alleviation of Alzheimer's disease pathogenesis.
    Rapaka D; Bitra VR; Challa SR; Adiukwu PC
    Neurochem Int; 2022 May; 155():105311. PubMed ID: 35218870
    [TBL] [Abstract][Full Text] [Related]  

  • 13. mTOR Signaling and Neural Stem Cells: The Tuberous Sclerosis Complex Model.
    Polchi A; Magini A; Meo DD; Tancini B; Emiliani C
    Int J Mol Sci; 2018 May; 19(5):. PubMed ID: 29772672
    [TBL] [Abstract][Full Text] [Related]  

  • 14. mTOR and the differentiation of mesenchymal stem cells.
    Xiang X; Zhao J; Xu G; Li Y; Zhang W
    Acta Biochim Biophys Sin (Shanghai); 2011 Jul; 43(7):501-10. PubMed ID: 21642276
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Modulation of TSC-mTOR signaling on immune cells in immunity and autoimmunity.
    Yang H; Wang X; Zhang Y; Liu H; Liao J; Shao K; Chu Y; Liu G
    J Cell Physiol; 2014 Jan; 229(1):17-26. PubMed ID: 23804073
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Growing knowledge of the mTOR signaling network.
    Huang K; Fingar DC
    Semin Cell Dev Biol; 2014 Dec; 36():79-90. PubMed ID: 25242279
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Role of the Mammalian Target of Rapamycin (mTOR) in Pulmonary Fibrosis.
    Lawrence J; Nho R
    Int J Mol Sci; 2018 Mar; 19(3):. PubMed ID: 29518028
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Knockdown of insulin-like growth factor 1 exerts a protective effect on hypoxic injury of aged BM-MSCs: role of autophagy.
    Yang M; Wen T; Chen H; Deng J; Yang C; Zhang Z
    Stem Cell Res Ther; 2018 Oct; 9(1):284. PubMed ID: 30359321
    [TBL] [Abstract][Full Text] [Related]  

  • 19. mTOR and vascular remodeling in lung diseases: current challenges and therapeutic prospects.
    Goncharova EA
    FASEB J; 2013 May; 27(5):1796-807. PubMed ID: 23355268
    [TBL] [Abstract][Full Text] [Related]  

  • 20. mTOR Promotes Antiviral Humoral Immunity by Differentially Regulating CD4 Helper T Cell and B Cell Responses.
    Ye L; Lee J; Xu L; Mohammed AU; Li W; Hale JS; Tan WG; Wu T; Davis CW; Ahmed R; Araki K
    J Virol; 2017 Feb; 91(4):. PubMed ID: 27974559
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.